Retractable Technologies Inc Receivables Turnover Ratio (RVP), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Retractable Technologies Inc  (NYSEAMER: RVP)
 

Retractable Technologies Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Retractable Technologies Inc's ability to collect accounts receivable sequentially worsen to 4.14, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Retractable Technologies Inc's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 88 days, from 79 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 445 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2403 to 2890.

What is Receivable Turnover Ratio?
What is Retractable Technologies Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RVP Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 11.67 % 30.21 % 1.51 % -2.73 % 72.4 %
Y / Y Revenue Change -27.21 % -13.67 % 4.03 % -6.39 % 64.08 %
Receivable Turnover Ratio (TTM) 4.14 4.61 5.01 4.98 5.03
RVP's Total Ranking # 2890 # 2403 # 2548 # 2926 # 2831
Accounts Receivable average collection period days 88 79 73 73 73
Seq. Receivable Change 29.41 % -11.72 % -6.33 % 4.35 % 50.88 %
Seq. Revenue Change 0.55 % -24.13 % -2.54 % -2.09 % 19.26 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 446
Overall Market # 2890

Receivable Turnover Ratio Statistics
High Average Low
8.56 6.13 2.73
(Sep 30 2017)   (Sep 30 2023)





RVP Company Profile • Back to RVP Efficiency Comparisons • Compare RVP Receivables Turnover Ratio to its Competitors

Financial Statements
Retractable Technologies Inc's Accounts Receivable $ 9 Millions Visit RVP's Balance sheet
Retractable Technologies Inc's Sales TTM $ 33 Millions Visit RVP's Income Statement
Sources of RVP's Revenues Visit RVP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RVP's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RVP's Growth Rates RVP's Roa RVP's Inventory Turnover Ratio RVP's Dividend Comparisons
RVP's Profitability Ratios RVP's Roi RVP's Asset Turnover Ratio RVP's Dividend Growth
RVP's Valuation Ratios RVP's Roe RVP's Financial Strength Ratios RVP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Kestra Medical Technologies Ltd   10.00 $ 105.939  Millions$ 10.590  Millions
United Therapeutics Corporation  9.93 $ 3,154.500  Millions$ 317.550  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
The Oncology Institute Inc   9.66 $ 587.244  Millions$ 60.780  Millions
Sharps Technology Inc   9.65 $ 1.960  Millions$ 0.203  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
Septerna Inc   9.42 $ 98.882  Millions$ 10.501  Millions
Biofrontera Inc   9.33 $ 45.956  Millions$ 4.928  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
The Pennant Group Inc   9.27 $ 1,101.710  Millions$ 118.798  Millions
Crinetics Pharmaceuticals Inc   9.25 $ 42.156  Millions$ 4.558  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Myomo Inc   9.24 $ 44.242  Millions$ 4.790  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Bioaffinity Technologies Inc   9.18 $ 5.901  Millions$ 0.643  Millions
Pavmed Inc   9.16 $ 0.126  Millions$ 0.014  Millions
Clene Inc   9.16 $ 0.197  Millions$ 0.022  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
Lexicon Pharmaceuticals Inc   9.14 $ 41.469  Millions$ 4.535  Millions
Novavax inc   9.06 $ 413.796  Millions$ 45.668  Millions
Nuvation Bio Inc   9.05 $ 169.551  Millions$ 18.737  Millions
Cue Biopharma Inc   9.04 $ 37.654  Millions$ 4.165  Millions
Sunshine Biopharma Inc   9.03 $ 35.347  Millions$ 3.916  Millions
Biocryst Pharmaceuticals Inc   9.00 $ 940.613  Millions$ 104.543  Millions
Edwards Lifesciences Corporation  8.99 $ 6,512.500  Millions$ 724.750  Millions
Cannapharmarx Inc   8.86 $ 1.699  Millions$ 0.192  Millions
Grail Inc   8.85 $ 165.263  Millions$ 18.670  Millions
Guardant Health Inc   8.84 $ 1,183.105  Millions$ 133.772  Millions
Zomedica Corp   8.84 $ 35.903  Millions$ 4.063  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.